Annual Revenue
$2.54 M
+$833.10 K+48.81%
01 December 2023
Summary:
Xenetic Biosciences annual revenue is currently $2.54 million, with the most recent change of +$833.10 thousand (+48.81%) on 01 December 2023. During the last 3 years, it has risen by +$2.10 million (+481.37%). XBIO annual revenue is now -66.51% below its all-time high of $7.58 million, reached on 31 December 2017.XBIO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$614.20 K
-$112.20 K-15.45%
01 September 2024
Summary:
Xenetic Biosciences quarterly revenue is currently $614.20 thousand, with the most recent change of -$112.20 thousand (-15.45%) on 01 September 2024. Over the past year, it has increased by +$3000.00 (+0.49%). XBIO quarterly revenue is now -91.81% below its all-time high of $7.50 million, reached on 31 December 2017.XBIO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.52 M
+$3000.00+0.12%
01 September 2024
Summary:
Xenetic Biosciences TTM revenue is currently $2.52 million, with the most recent change of +$3000.00 (+0.12%) on 01 September 2024. Over the past year, it has increased by +$168.40 thousand (+7.15%). XBIO TTM revenue is now -66.73% below its all-time high of $7.58 million, reached on 31 December 2017.XBIO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.8% | +0.5% | +7.2% |
| 3 y3 years | +481.4% | +75.8% | +157.7% |
| 5 y5 years | - | - | - |
XBIO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +481.4% | -15.4% | +84.7% | -0.7% | +157.7% |
| 5 y | 5 years | at high | >+9999.0% | -15.4% | +3491.8% | -0.7% | >+9999.0% |
| alltime | all time | -66.5% | >+9999.0% | -91.8% | +7777.5% | -66.7% | >+9999.0% |
Xenetic Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $614.20 K(-15.4%) | $2.52 M(+0.1%) |
| June 2024 | - | $726.40 K(+42.2%) | $2.52 M(+3.1%) |
| Mar 2024 | - | $510.80 K(-24.0%) | $2.44 M(-3.7%) |
| Dec 2023 | $2.54 M(+48.8%) | $672.00 K(+9.9%) | $2.54 M(+7.9%) |
| Sept 2023 | - | $611.20 K(-6.1%) | $2.35 M(+9.1%) |
| June 2023 | - | $651.00 K(+7.5%) | $2.16 M(+12.2%) |
| Mar 2023 | - | $605.80 K(+24.4%) | $1.92 M(+12.7%) |
| Dec 2022 | $1.71 M(+47.1%) | $487.00 K(+17.5%) | $1.71 M(+9.9%) |
| Sept 2022 | - | $414.30 K(-0.6%) | $1.55 M(+4.4%) |
| June 2022 | - | $416.70 K(+7.1%) | $1.49 M(+9.5%) |
| Mar 2022 | - | $389.00 K(+17.0%) | $1.36 M(+17.0%) |
| Dec 2021 | $1.16 M(+165.7%) | $332.60 K(-4.8%) | $1.16 M(+18.5%) |
| Sept 2021 | - | $349.30 K(+21.5%) | $979.40 K(+31.3%) |
| June 2021 | - | $287.60 K(+50.4%) | $746.00 K(+30.6%) |
| Mar 2021 | - | $191.20 K(+26.4%) | $571.30 K(+30.8%) |
| Dec 2020 | $436.90 K | $151.30 K(+30.5%) | $436.80 K(+44.3%) |
| Sept 2020 | - | $115.90 K(+2.7%) | $302.60 K(+62.1%) |
| June 2020 | - | $112.90 K(+99.1%) | $186.70 K(+153.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $56.70 K(+231.6%) | $73.80 K(+331.6%) |
| Dec 2019 | $17.10 K(-99.8%) | $17.10 K(-99.8%) | $17.10 K(-99.8%) |
| Dec 2017 | $7.58 M(+152.8%) | $7.50 M(+8723.5%) | $7.58 M(+145.9%) |
| Sept 2017 | - | $85.00 K(-97.2%) | $3.08 M(+2.8%) |
| Dec 2016 | $3.00 M(+200.0%) | $3.00 M(>+9900.0%) | $3.00 M(+4431.7%) |
| Dec 2013 | $1.00 M(+932.0%) | - | - |
| Nov 2013 | - | $2200.00(-127.5%) | $66.20 K(-31.8%) |
| Aug 2013 | - | -$8000.00(-120.3%) | $97.00 K(-26.3%) |
| Aug 2013 | $96.90 K(-67.0%) | - | - |
| May 2013 | - | $39.40 K(+20.9%) | $131.60 K(+2.3%) |
| Feb 2013 | - | $32.60 K(-1.2%) | $128.60 K(-2.6%) |
| Dec 2012 | $293.60 K(+160.3%) | - | - |
| Nov 2012 | - | $33.00 K(+24.1%) | $132.00 K(+17.1%) |
| Aug 2012 | - | $26.60 K(-26.9%) | $112.70 K(+30.9%) |
| Aug 2012 | $112.80 K | - | - |
| May 2012 | - | $36.40 K(+1.1%) | $86.10 K(+73.2%) |
| Feb 2012 | - | $36.00 K(+162.8%) | $49.70 K(+262.8%) |
| Nov 2011 | - | $13.70 K | $13.70 K |
FAQ
- What is Xenetic Biosciences annual revenue?
- What is the all time high annual revenue for Xenetic Biosciences?
- What is Xenetic Biosciences annual revenue year-on-year change?
- What is Xenetic Biosciences quarterly revenue?
- What is the all time high quarterly revenue for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly revenue year-on-year change?
- What is Xenetic Biosciences TTM revenue?
- What is the all time high TTM revenue for Xenetic Biosciences?
- What is Xenetic Biosciences TTM revenue year-on-year change?
What is Xenetic Biosciences annual revenue?
The current annual revenue of XBIO is $2.54 M
What is the all time high annual revenue for Xenetic Biosciences?
Xenetic Biosciences all-time high annual revenue is $7.58 M
What is Xenetic Biosciences annual revenue year-on-year change?
Over the past year, XBIO annual revenue has changed by +$833.10 K (+48.81%)
What is Xenetic Biosciences quarterly revenue?
The current quarterly revenue of XBIO is $614.20 K
What is the all time high quarterly revenue for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly revenue is $7.50 M
What is Xenetic Biosciences quarterly revenue year-on-year change?
Over the past year, XBIO quarterly revenue has changed by +$3000.00 (+0.49%)
What is Xenetic Biosciences TTM revenue?
The current TTM revenue of XBIO is $2.52 M
What is the all time high TTM revenue for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM revenue is $7.58 M
What is Xenetic Biosciences TTM revenue year-on-year change?
Over the past year, XBIO TTM revenue has changed by +$168.40 K (+7.15%)